<DOC>
	<DOCNO>NCT01626456</DOCNO>
	<brief_summary>This study evaluate safety durability effect ALKS 9072 ( also know ALKS 9070 ) long-term treatment subject stable schizophrenia .</brief_summary>
	<brief_title>A Long-term Safety Study ALKS 9072 ( Also Known ALKS 9070 )</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<criteria>( Subjects participate ALK9072003 ) Completed ALK9072003 Day 85 visit Continues require treatment antipsychotic medication ( New Subjects ) On stable dose oral antipsychotic medication Diagnosis chronic schizophrenia base Diagnostic Statistical Manual Mental Disorders , Fourth Edition ( DSMIV ) criteria clinically stable Has able achieve outpatient status 3 month prior screen Body Mass Index ( BMI ) 18.5 40.0 kg/m2 ( inclusive ) Resides stable living situation ( Subjects participate ALK9072003 ) Abnormal clinical laboratory , vital sign , electrocardiogram ( ECG ) find participation study ALK9072003 clinically relevant relate study drug Missed 1 schedule study visit participation study ALK9072003 Has significant unstable medical condition would preclude safe completion current study Subject pregnant breastfeeding Subject expect incarcerate next 12 month , pending legal action may impact compliance study participation procedure ( New Subjects ) History poor inadequate clinical response treatment aripiprazole History treatment resistance Diagnosis current substance dependence ( include alcohol ) Pregnant , lactating , breastfeeding Has receive longacting intramuscular antipsychotic medication within 60 day prior screen Currently involuntary hospitalization Current expect incarceration Additional inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>